BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15779346)

  • 1. [Natural history of glucose intolerance groups].
    Ito C
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():63-6. PubMed ID: 15779346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].
    Kuzuya T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():15-20. PubMed ID: 15779339
    [No Abstract]   [Full Text] [Related]  

  • 4. [IFG and IGT in Europe and America: the present and prospective].
    Tsujii S; Kuzuya H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mild glucose intolerance in the elderly].
    Oba K; Nakano H; Okazaki K
    Nihon Rinsho; 1996 Oct; 54(10):2773-8. PubMed ID: 8914443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impaired glucose tolerance in the elderly--prevalence, pathogenesis and management].
    Ito H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():341-4. PubMed ID: 15779400
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
    Igarashi M; Tominaga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplant-associated hyperglycemia: shedding light on the mechanisms.
    Reese PP; Bloom RD
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):560-2. PubMed ID: 20338965
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hereditary background and natural history in glucose-intolerance group].
    Ito C
    Nihon Rinsho; 1996 Oct; 54(10):2636-42. PubMed ID: 8914421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose tolerance: obesity and inactivity as modifiable risk factors.
    Taylor K
    Adv Nurse Pract; 2001 Dec; 9(12):59-61. PubMed ID: 12400355
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemia management in patients with impaired glucose tolerance].
    Asano M; Yamada N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology on impaired glucose tolerance].
    Tominaga M
    Nihon Rinsho; 1996 Oct; 54(10):2643-8. PubMed ID: 8914422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of diabetes--importance of early diagnosis and interventions in IGT & IFG].
    Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():49-54. PubMed ID: 15779344
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose].
    Nishi Y; Yamada Y; Fukushima M; Seino Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():151-4. PubMed ID: 15779360
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term significance of gestational carbohydrate intolerance: a longitudinal study.
    Schranz AG; Savona-Ventura C
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):219-22. PubMed ID: 12148085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of diabetes mellitus in adults. Risk factor reduction is key.
    Coyle CG
    Adv Nurse Pract; 2003 May; 11(5):32-7; quiz 38. PubMed ID: 12754980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.